Mona Eisermann
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Therapeutic Silencing of Tmprss6 Reduces Iron-Induced Inflammation and Prolongs Survival in MDS Mice.
Journal: American journal of hematology
Published: October 06, 2025
Enhancing hemostasis potency in hemophilia with a small interfering ribonucleic acid targeting protein S.
Journal: Journal of thrombosis and haemostasis : JTH
Published: December 29, 2024
Preclinical Toxicological Assessment of A Novel siRNA, SLN360, Targeting Elevated Lipoprotein (a) in Cardiovascular Disease.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: June 23, 2022
Pre-clinical assessment of SLN360, a novel siRNA targeting LPA, developed to address elevated lipoprotein (a) in cardiovascular disease.
Journal: Atherosclerosis
Published: October 30, 2021
Therapeutic Small Interfering RNA Targeting Complement C3 in a Mouse Model of C3 Glomerulopathy.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 26, 2021
SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of β-thalassaemia.
Journal: British journal of haematology
Published: February 03, 2021
Delivery of therapeutic siRNA to the lung endothelium via novel Lipoplex formulation DACC.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 18, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026